ORKA-002 interim Phase 1 data demonstrates a half-life of 75-80 days supporting potential for twice-per-year dosing in ...

Today South Australia Police (SAPOL) launched the landmark 'Go for PSO' campaign, showcasing the diverse and meaningful career opportunities available ...

A new winter storm is on track to bring widespread snow, a wintry mix, and gusty winds to the Northeast, with hazardous ...

Topline data were announced from a phase 3b trial evaluating the concomitant use of ixekizumab and tirzepatide in active PsA and obesity.

Air Charter Scotland has announced the relaunch of its Aberdeen-Wick route, with flights set to commence on 14 January.

In an open-label phase 3b trial, the co-administration of Lilly’s IL-17A antagonist Taltz (ixekizumab) and dual GIP/GLP-1 ...

Eli Lilly said combining Taltz and Zepbound improved arthritis symptoms and drove meaningful weight loss, outperforming Taltz ...

The TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis ...

Experts and private sector executives acknowledged the government’s efforts to develop the energy sector but pointed out ...

South Australia's first-ever campaign to drive police security officer (PSO) applications will launch this week as part of the State Government's ...

Oklahoma balances oil and gas roots with growing wind and solar, debating taxes, reliability and regulation as energy demand ...